3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia | Phase 4 | Completed | BioXcel Therapeutics Inc | 29 | 2023-10-02 | 2026-08-11 |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | University of Michigan | 143 | 2020-01-16 | 2026-06-17 |
| Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia Memantine, Placebos - Schizophrenia, Schizo Affective Disorder | Phase 4 | Completed | University of California, San Diego | 42 | 2018-04-01 | 2022-12-21 |
Psychotic Disorders (3) · Schizophrenia (3) · Bipolar Disorder (2) · Psychomotor Agitation (1)
Mental Disorders (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Bipolar and Related Disorders (2) · Mood Disorders (2) · Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Dyskinesias (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Psychomotor Disorders (1) · Signs and Symptoms (1)
Dexmedetomidine (1) · Lorazepam (1) · Memantine (1)
BioXcel Therapeutics Inc (1) · University of California, San Diego (1) · University of Michigan (1)
United States (3)
BioXcel MM, MD (1) · Stephan Taylor, MD (1)
R01MH118634 (1)